Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
The Journal of Clinical Investigation
|
June 1, 2021
Calcineurin inhibitors target Lck activation in graft-versus-host disease
Nicole M Carter, Joel L Pomerantz
Advances in Biological Regulation
|
March 7, 2022
CARD11 signaling in regulatory T cell development and function
Nicole M Carter, Joel L Pomerantz
Diagnostic Microbiology and Infectious Disease
|
May 12, 2024
In vitro antibacterial activity of sulbactam-durlobactam in combination with other antimicrobial agents against Acinetobacter baumannii-calcoaceticus complex
Sarah M McLeod, Nicole M Carter, Patricia A Bradford, et al.
ACS Infectious Diseases
|
December 9, 2020
Ceftazidime-Avibactam Resistance Mutations V240G, D179Y, and D179Y/T243M in KPC-3 β-Lactamase Do Not Alter Cefpodoxime-ETX1317 Susceptibility
Adam B Shapiro, Samir H Moussa, Nicole M Carter, et al.
ACS Infectious Diseases
|
August 25, 2017
Reversibility of Covalent, Broad-Spectrum Serine β-Lactamase Inhibition by the Diazabicyclooctenone ETX2514
Adam B Shapiro, Ning Gao, Haris Jahić, et al.
Journal of Clinical Microbiology
|
December 14, 2023
Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests
Sarah M McLeod, Nicole M Carter, Michael D Huband, et al.
ACS Infectious Diseases
|
April 8, 2020
<i>In Vitro</i> Characterization of ETX1317, a Broad-Spectrum β-Lactamase Inhibitor That Restores and Enhances β-Lactam Activity against Multi-Drug-Resistant <i>Enterobacteriales</i>, Including Carbapenem-Resistant Strains
Alita A Miller, Adam B Shapiro, Sarah M McLeod, et al.
Antimicrobial Agents and Chemotherapy
|
October 16, 2023
Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of <i>Acinetobacter baumannii</i>
Samir H Moussa, Adam B Shapiro, Sarah M McLeod, et al.
Journal of Neuroimmunology
|
September 21, 2010
Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis
Giang T Tran, Suzanne J Hodgkinson, Nicole M Carter, et al.
Frontiers in Immunology
|
October 5, 2018
Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease
Jacquelyn R Bedsaul, Nicole M Carter, Katelynn E Deibel, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
The Journal of Clinical Investigation
|
June 1, 2021
Calcineurin inhibitors target Lck activation in graft-versus-host disease
Nicole M Carter, Joel L Pomerantz
Advances in Biological Regulation
|
March 7, 2022
CARD11 signaling in regulatory T cell development and function
Nicole M Carter, Joel L Pomerantz
Diagnostic Microbiology and Infectious Disease
|
May 12, 2024
In vitro antibacterial activity of sulbactam-durlobactam in combination with other antimicrobial agents against Acinetobacter baumannii-calcoaceticus complex
Sarah M McLeod, Nicole M Carter, Patricia A Bradford, et al.
ACS Infectious Diseases
|
December 9, 2020
Ceftazidime-Avibactam Resistance Mutations V240G, D179Y, and D179Y/T243M in KPC-3 β-Lactamase Do Not Alter Cefpodoxime-ETX1317 Susceptibility
Adam B Shapiro, Samir H Moussa, Nicole M Carter, et al.
ACS Infectious Diseases
|
August 25, 2017
Reversibility of Covalent, Broad-Spectrum Serine β-Lactamase Inhibition by the Diazabicyclooctenone ETX2514
Adam B Shapiro, Ning Gao, Haris Jahić, et al.
Journal of Clinical Microbiology
|
December 14, 2023
Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests
Sarah M McLeod, Nicole M Carter, Michael D Huband, et al.
ACS Infectious Diseases
|
April 8, 2020
<i>In Vitro</i> Characterization of ETX1317, a Broad-Spectrum β-Lactamase Inhibitor That Restores and Enhances β-Lactam Activity against Multi-Drug-Resistant <i>Enterobacteriales</i>, Including Carbapenem-Resistant Strains
Alita A Miller, Adam B Shapiro, Sarah M McLeod, et al.
Antimicrobial Agents and Chemotherapy
|
October 16, 2023
Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of <i>Acinetobacter baumannii</i>
Samir H Moussa, Adam B Shapiro, Sarah M McLeod, et al.
Journal of Neuroimmunology
|
September 21, 2010
Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis
Giang T Tran, Suzanne J Hodgkinson, Nicole M Carter, et al.
Frontiers in Immunology
|
October 5, 2018
Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease
Jacquelyn R Bedsaul, Nicole M Carter, Katelynn E Deibel, et al.
Page
of 2